You already pay for three kinds of care. An insurance premium keeps a primary-care doctor who will not prescribe a GLP-1. A membership app writes the prescription. A telehealth service signs off on whatever paperwork the other two need. Each one sees a slice of you, and none of them sees the rest. Folding all of that into one clinician sounds sensible until the obvious question arrives: what if I am not accepted? At GoodLife Health the checkout comes before the clinician's review, so the worry is fair, and it should be answered before you spend anything or cancel anything.
The patient in this piece is a composite of situations like yours, not a real person. The short answer is this. If a GoodLife Health clinician cannot accept you into care, the $598 charged at sign-up is refunded in full. If you are accepted, the first two months are non-refundable, and any medication a pharmacy bills you for follows that pharmacy's own return and refund policy. What follows explains what acceptance means, why it is a different question from whether you will get a prescription, and what to keep in place while you wait to hear.
- A licensed clinician decides whether to accept you, after the eligibility check, the intake and the checkout.
- Not accepted: the $598 is refunded in full. Accepted: the first two months are non-refundable, and medication follows your pharmacy's own policy.
- Acceptance into care and a GLP-1 prescription are separate decisions; the membership never promises a medication.
- Keep your insurance and your current prescription until a clinician has accepted you.
- If accepted, $299 a month covers four lab panels a year, messaging and video visits; your pharmacy bills medication at its own price.
Three services, and nobody who sees all of you
Start with what each piece of your current setup does well, because each does something. Your insurance plan protects you against the large, rare bill: the hospital stay, the specialist, the emergency room. Your primary-care doctor knows your history, at least the parts that came up in the visits you have had. The app moved quickly when your doctor would not. The telehealth service filled the gaps in paperwork. None of that was a mistake; you assembled care from what was on offer.
The trouble shows up in the space between them. Your doctor may have ordered a lipid panel last year that the app never saw. The app asked its own intake questions and set a dose, but no one there has your A1c from the spring unless you typed it in. The telehealth clinician who signed a form saw neither. When a side effect appears a few weeks in, you have three possible places to send a message and a real chance that each will point you to one of the others. When a dose goes up, the person raising it may never have read your liver enzymes.
You are also paying three times for what should be one relationship. The premium buys access to a primary-care visit; traditional primary-care appointments average 18 minutes, and the doctor in that room has already told you where they stand on GLP-1 medication. The app's fee buys the prescription. The telehealth fee buys a signature. What none of the three sells is someone who orders your labs, reads them, prescribes from them, and checks again three months later.
That is the case for moving. The case against moving, at least for now, is the risk you can feel: you leave the app, sign up somewhere new, and then hear that you have not been accepted. For a stretch you might have no prescription source at all, and some money tied up in a place that turned you down. That fear is reasonable. It is also mostly avoidable, once you see how the steps are ordered and what each one costs.
What "accepted" means, and why you pay before you hear
The path at GoodLife Health has four steps, always in the same order: the eligibility check, the intake, the checkout, then a clinician's review. The $598 is charged at checkout and covers the first two months of the $299 membership. The clinician's decision comes after that.
So the money moves before the answer. That order is the reason the refund rule exists, and the rule is simple. If the clinician cannot accept you into care, the $598 comes back to you in full. Once you are accepted, the first two months are non-refundable. Medication is never part of that money, because GoodLife Health does not bill for it; whatever a pharmacy charges you follows that pharmacy's own return and refund policy.
Acceptance is a clinical decision made by a person. A licensed clinician reads your intake and decides whether to take on your care. Cassandra, the intelligence layer in the portal, organizes the intake and surfaces trends for the clinician; she does not diagnose or prescribe, and she does not decide who is accepted. Not everyone is accepted. This piece will not guess at your reasons in advance, because there is no honest way to do that from the outside. The decision is made on your intake, by the clinician reading it.
What the clinician is deciding helps explain why acceptance is a real step. The practice is precision direct primary care for cardiometabolic optimization: diagnosis first, then treatment, then the long haul. It is labs-first. Accepting a patient means taking clinical responsibility for that patient over time, under the clinician's own licence, within that scope. The Learning Center's guide to what a direct primary care membership includes puts the test plainly: you should know whether your health goals fall inside a practice's clinical scope before you enroll. The clinician's review is the practice applying the same test from its side.
That is a different shape from the app you use now. Many prescription-first services route an asynchronous intake form to whichever provider is available, and in that model the intake can lead straight to a prescription. Here, acceptance and prescribing are two separate decisions, and that difference matters more to your money than anything else in this article.
What none of the three sells is someone who orders your labs, reads them, prescribes from them, and checks again three months later.
Acceptance into care is the first decision. Whether a GLP-1 is indicated is the second, and it comes later. Baseline labs come before any GLP-1 protocol begins, because a protocol built without them is a guess. Clinicians evaluate whether a GLP-1 such as Wegovy or Zepbound fits using your BMI, your metabolic labs and your health history. The membership never promises a medication. A clinician may accept you and then judge, once the labs are read, that a GLP-1 is indicated, or that it is not.
Accepting a patient into care and prescribing a medication are separate clinical judgments. A GLP-1 is prescribed only when the clinician finds it indicated, after the baseline labs have been read.
Put the two decisions next to the refund rule and the real risk comes into focus. The refund turns on the first decision, acceptance into care, and not on which prescription follows: turned away, you get the $598 back in full; accepted, the first two months are non-refundable. The scenario you fear, being turned away after paying, costs you time and leaves your money whole. The scenario worth thinking about is the other one: being accepted, and then learning that the medication you wanted is not what the clinician recommends. If the prescription is the only thing you want from a new arrangement, that is the risk to weigh, and it is better weighed now than discovered later.
Both outcomes, in money and in care
What happens at each step
| Step | What happens | Your money |
|---|---|---|
| Eligibility check | The first step, before anything else | Nothing charged yet |
| Intake | You give your history to the care team | Nothing charged yet |
| Checkout | You sign up | $598 charged, covering the first two months |
| Clinician's review: not accepted | The clinician cannot accept you into care | The $598 is refunded in full |
| Clinician's review: accepted | The clinician takes on your care; baseline labs come first | The first two months are non-refundable; then $299 a month, month to month |
| Medication, if indicated | Prescribed to the pharmacy you choose | Billed by that pharmacy at its own price, under its own return and refund policy |
If you are not accepted
The $598 is refunded in full; it is only after acceptance that the first two months become non-refundable. Since GoodLife Health never billed you for medication, there is nothing on that side to unwind with us. You are back where you started: the same insurance plan, the same primary-care doctor, and, if you followed the advice below, the same app and the same prescription.
That last part is the practical answer to most of the fear. Keep what you have until a clinician has accepted you. Do not cancel the app's prescription on the day you check out, and do not let your insurance lapse. The membership was never meant to replace insurance in any case. It pairs with insurance, which stays for catastrophic coverage, and it replaces the primary-care relationship. If the answer is no, nothing you depend on has been switched off.
If you are accepted
Once you are accepted, the first two months are non-refundable, and after that the membership runs month to month at $299. Over a full year that is $3,588. The membership fee is generally eligible for HSA or FSA pre-tax dollars, which matters if you have one of those accounts.
The fee covers clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in your hands, asynchronous messaging with the care team, and video visits. It is the same fee whatever medication is indicated and whatever the dose, with no molecule upcharge and no dose upcharge. The model is laid out in more depth in What Is GoodLife Health?
Medication is unbundled. When a clinician finds a medication indicated, it is prescribed to the pharmacy you choose, at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. The prescription is branded and FDA-approved: Wegovy, Zepbound, Mounjaro or Ozempic for GLP-1. For a sense of the self-pay side, the manufacturers published these prices in September 2026: through NovoCare, Wegovy pens at $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after, and the Wegovy pill from $149 a month at lower doses; through LillyDirect, Zepbound vials at $299 to $449 a month depending on dose. Those are the manufacturers' figures, and they can change.
If you hope insurance will pay for the medication instead, that question sits between you, your plan and the pharmacy. Prior authorization is the pharmacy's process. GoodLife Health does not run it, speed it up or promise its outcome, and it does not promise coverage.
What changes for the fragmentation is who holds the thread. One clinician orders the panel, reads it, decides on the prescription, and reads the next panel three months later to see what happened. The results come to you, so the history travels with you instead of sitting in three portals. If you already have a prescription from the app when you are accepted, tell your clinician about it at intake and let them decide how to handle the handover. That is their call to make with the full picture, which is the point of having one person make it.
Is it worth applying when the answer could be no?
For most people in your position, the attempt itself carries little downside. If you are turned down, you get the $598 back in full and lose the time it took to complete the check and the intake. If you are accepted, the first two months are non-refundable, and you have committed them to a clinician who will start with labs before any prescription.
So the useful question is whether you want what the second outcome gives you. If you want one clinician who measures before deciding, reads every result with you, and stays with the problem over months, the risk of a no costs little. If what you want is a specific drug on a specific date, an acceptance does not guarantee it, and the two non-refundable months could feel like a poor trade. Neither answer is wrong. They are different needs, and only one of them is what this membership is built for.
The order that protects you is simple: run the eligibility check, keep your insurance and your current prescription in place, complete the intake and checkout, and wait for the clinician's decision before you change anything else.
Who this is not for
If your aim is the lowest monthly price for a GLP-1, this is the wrong place. GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, and it says so. It does not prescribe compounded GLP-1, ever; the FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, and the prescription here is branded and FDA-approved.
It is also not for someone who needs a prescription promised before signing up, since acceptance does not include one. It is not for someone hoping to drop insurance, since the membership pairs with it. And it is not for anyone who wants to pay $598 to test whether a prescription will come: if you are not accepted, the $598 is refunded in full, but once you are accepted, those two months are non-refundable whatever the clinician recommends.
Related Reading
- What Is GoodLife Health? Direct Primary Care, Explained (2026)
- What Does Direct Primary Care Include in 2026
References
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss